Related Targets |
Mechanism CYP2D6 inhibitors [+4] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date18 Aug 2022 |
Mechanism CYP2D6 inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date30 Dec 1985 |
Mechanism CYP2D6 inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication- |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 May 2024 |
Sponsor / Collaborator |
Start Date20 Feb 2024 |
Sponsor / Collaborator |